Marking Rare Disease Day, Strand Life Sciences, a subsidiary of Reliance Industries and a leading genomics research company, has launched the StrandOmics Portal, an innovative digital platform designed to assist doctors in diagnosing rare diseases more efficiently.
Nita Ambani, Founder and Chairperson of the Reliance Foundation delivered the keynote address at the Harvard India Conference on Indian Business, Policy & Culture, where she said that the strength of India lies in its large youth population and the diaspora. She called the adoption of te
London [UK]/ Munich [Germany]/ New Delhi [India], February 4: Datar Cancer Genetics (DCG) has launched Exacta AI, a next generation multi-analyte AI-driven platform providing optimized treatment options for cancer patients who have exhausted the standard options. It integrates a 360° tu
Hasan Jasem Al Nowais, Managing Director and Group Chief Executive Officer of M42, emphasised that the UAE's healthcare system has become a global benchmark in preventive medicine, driven by Abu Dhabi and other emirates hosting advanced hospitals, pioneering robotic technologies, innovative
Leading genomics and bioinformatics company Strand Life Sciences, a subsidiary of Reliance Industries Limited, has launched a novel blood-based test for early detection of multiple cancers. Called CancerSpot, the test uses the latest globally accepted methylation profiling technology to iden
Mumbai (Maharashtra) [India], November 22: Lung cancer remains one of the most prevalent and deadly cancers globally, with approximately 2.2 million new cases diagnosed annually, contributing to 18% of all cancer-related deaths, according to the International Agency for Research on Cancer. I
Bengaluru (Karnataka) [India], October 23: 4baseCare, an Illumina Accelerator Company, which offers cutting-edge precision oncology solutions using advanced genomics and digital health technology, is excited to announce a strategic partnership to nurture technology transfer with Innovate Lif
Bengaluru (Karnataka) [India], October 17: MedGenome, a leading global genomics-driven diagnostics and research services company, proudly marks a decade of transformative contributions to healthcare. Founded in 2013, MedGenome has been at the forefront of integrating genomics into clinica
Researchers at Colorado State University discovered an alternative way for studying alterations during the DNA replication process in lab settings using genetically modified yeast. The novel methodology provides a clearer picture than current pharmacological methods for understanding cell cy
New Delhi [India], October 7: Lavanya The Label and Lavanya Marbles have forged an exclusive partnership with the Royal Family of Abu Dhabi in an exciting move that marks a significant milestone for both brands. This powerful family is already involved in various sectors including Genomics,
When cells divide, there is a substantial risk of genetic harm. After all, the cell must repeat its whole genetic material, including billions of genetic letters, before it can divide. This repeatedly produces "reading errors" in the genome. Other factors, including as exposure to sunlight,